Drug approval: Enfortumab vedotin-advanced urothelial carcinoma (which have previously received platinum-containing chemotherapy and immunotherapy)
Matte, Paul ; Campedel, Luca
Bulletin du cancer, 2022-07
[Periódico revisado por pares]
France
Sem texto completo